Caseware UK (AP4) 2023.0.135 2023.0.135 2024-09-302024-09-302025-05-09sale of medical equipment02023-10-01falsetruetrue0 08689983 2023-10-01 2024-09-30 08689983 2022-10-01 2023-09-30 08689983 2024-09-30 08689983 2023-09-30 08689983 c:Director1 2023-10-01 2024-09-30 08689983 d:CurrentFinancialInstruments 2024-09-30 08689983 d:CurrentFinancialInstruments 2023-09-30 08689983 d:CurrentFinancialInstruments d:WithinOneYear 2024-09-30 08689983 d:CurrentFinancialInstruments d:WithinOneYear 2023-09-30 08689983 d:ShareCapital 2024-09-30 08689983 d:ShareCapital 2023-09-30 08689983 d:RetainedEarningsAccumulatedLosses 2024-09-30 08689983 d:RetainedEarningsAccumulatedLosses 2023-09-30 08689983 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2024-09-30 08689983 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2023-09-30 08689983 c:OrdinaryShareClass1 2023-10-01 2024-09-30 08689983 c:OrdinaryShareClass1 2024-09-30 08689983 c:OrdinaryShareClass1 2023-09-30 08689983 c:EntityHasNeverTraded 2023-10-01 2024-09-30 08689983 c:FRS102 2023-10-01 2024-09-30 08689983 c:AuditExempt-NoAccountantsReport 2023-10-01 2024-09-30 08689983 c:FullAccounts 2023-10-01 2024-09-30 08689983 c:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 08689983 2 2023-10-01 2024-09-30 08689983 e:PoundSterling 2023-10-01 2024-09-30 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 08689983









MEDICAL MANUFACTURERS EUROPE LIMITED







UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2024

 
MEDICAL MANUFACTURERS EUROPE LIMITED
REGISTERED NUMBER: 08689983

BALANCE SHEET
AS AT 30 SEPTEMBER 2024

2024
2023
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
100
867

Cash at bank and in hand
 5 
559
1,397

  
659
2,264

Creditors: amounts falling due within one year
 6 
(138)
(1,458)

Net current assets
  
 
 
521
 
 
806

Total assets less current liabilities
  
521
806

  

Net assets
  
521
806


Capital and reserves
  

Called up share capital 
 8 
100
100

Profit and loss account
  
421
706

  
521
806


Page 1

 
MEDICAL MANUFACTURERS EUROPE LIMITED
REGISTERED NUMBER: 08689983
    
BALANCE SHEET (CONTINUED)
AS AT 30 SEPTEMBER 2024

For the year ended 30 September 2024 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 9 May 2025.




................................................
Richard Walmsley
Director

The notes on pages 3 to 5 form part of these financial statements.

Page 2

 
MEDICAL MANUFACTURERS EUROPE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

1.


General information

Medical Manufacturers Europe Limited is a company limited by shares and incorporated in England. The is dormant and did not trade during the year.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

 
2.2

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.3

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

 
2.4

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.5

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.6

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

The Company has elected to apply the recognition and measurement provisions of IFRS 9 Financial Instruments (as adopted by the UK Endorsement Board) with the disclosure requirements of Sections 11 and 12 and the other presentation requirements of FRS 102.

Financial instruments are recognised in the Company's Balance sheet when the Company becomes party to the contractual provisions of the instrument.

Page 3

 
MEDICAL MANUFACTURERS EUROPE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2.Accounting policies (continued)

 
2.7

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The Company has no employees other than the director, who did not receive any remuneration (2023 - £NIL).


4.


Debtors

2024
2023
£
£


Other debtors
-
767

Called up share capital not paid
100
100

100
867



5.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
559
1,397

559
1,397



6.


Creditors: Amounts falling due within one year

2024
2023
£
£

Accruals and deferred income
138
1,458

138
1,458


Page 4

 
MEDICAL MANUFACTURERS EUROPE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

7.


Financial instruments

2024
2023
£
£

Financial assets


Financial assets measured at fair value through profit or loss
559
1,397




Financial assets measured at fair value through profit or loss comprise cash at bank.


8.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



100 (2023 - 100) Ordinary shares of £1.00 each
100
100



9.


Controlling party

The company is controlled by Gordon Gardner Pty Ltd, an Australian based company, who owns all of the shares in the company.
 
Page 5